RAYMOND JAMES & ASSOCIATES - GENMAB A/S ownership

GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 141 filers reported holding GENMAB A/S in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of GENMAB A/S
ValueSharesWeighting
Q3 2023$6,932,628
-6.1%
196,559
+1.2%
0.01%0.0%
Q2 2023$7,380,126
-1.5%
194,163
-2.2%
0.01%
-14.3%
Q1 2023$7,496,147
-7.4%
198,521
+3.9%
0.01%0.0%
Q4 2022$8,095,555
+17.1%
191,023
-11.2%
0.01%0.0%
Q3 2022$6,913,000
-14.5%
215,155
-13.5%
0.01%
-12.5%
Q2 2022$8,085,000
+8.6%
248,858
+20.9%
0.01%
+33.3%
Q1 2022$7,446,000
+9.8%
205,815
+20.1%
0.01%
+20.0%
Q4 2021$6,782,000
-5.6%
171,431
+4.3%
0.01%
-16.7%
Q3 2021$7,181,000
+13.9%
164,329
+6.4%
0.01%0.0%
Q2 2021$6,307,000
+128.0%
154,462
+83.4%
0.01%
+100.0%
Q1 2021$2,766,000
-24.9%
84,243
-6.9%
0.00%
-25.0%
Q4 2020$3,681,000
+28.0%
90,533
+15.3%
0.00%0.0%
Q3 2020$2,875,000
+12.4%
78,531
+4.1%
0.00%
+33.3%
Q2 2020$2,557,000
-2.3%
75,450
-38.9%
0.00%
-25.0%
Q1 2020$2,617,000
-2.2%
123,514
+3.1%
0.00%
+33.3%
Q4 2019$2,675,000
+18.4%
119,784
+7.4%
0.00%0.0%
Q3 2019$2,260,000111,5510.00%
Other shareholders
GENMAB A/S shareholders Q1 2020
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 242,848$9,169,9403.80%
Capricorn Fund Managers Ltd 110,643$4,177,8801.28%
Arlington Capital Management, Inc. 35,591$1,343,9161.26%
XY Capital Ltd 76,884$2,903,1401.13%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 88,000$3,322,8800.93%
TORRAY INVESTMENT PARTNERS LLC 110,807$4,184,0720.75%
Hardman Johnston Global Advisors LLC 585,139$22,094,8490.72%
Yorktown Management & Research Co Inc 16,600$626,8160.68%
First Light Asset Management, LLC 160,025$6,042,5440.54%
MIRABELLA FINANCIAL SERVICES LLP 28,260$2,505,8550.38%
View complete list of GENMAB A/S shareholders